Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

NCT00380029

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma

NCT00496587

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

NCT01015963

Conditions: Bladder Cancer, Breast Cancer, Breast Diseases, +50 more
Locations: Not specified

View Trial Details

Completed

Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.

NCT00330499

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations: Liverpool Hospital Liverpool, New South Wales, Australia

Calvary Mater Newcastle Newcastle, New South Wales, Australia

Nepean Cancer Care Centre Penrith, New South Wales, Australia

Prince of Wales Hospital Randwick, New South Wales, Australia

View all 22 locations

View Trial Details

Completed

Cancer in Patients With Gabapentin (GPRD)

NCT01236053

Conditions: Adenocarcinoma, Anal Cancer, Anus Diseases, +82 more
Locations: Not specified

View Trial Details

Completed

Pillars4Life Trial

NCT02465892

Conditions: Adnexal Diseases, Anxiety Disorders, Bladder Cancer, +71 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

NCT01132911

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Tabectedin to Treat Children and Adolescents With Cancer

NCT01453283

Conditions: Adenocarcinoma, Brain Diseases, Brain Neoplasms, +45 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00357760

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States

Porter Adventist Hospital Denver, Colorado, United States

View all 205 locations

View Trial Details

Completed

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

NCT02883153

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Radboudumc Nijmegen, Netherlands

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions